Sen. Lamar Alexander, R-Tenn., was eager to ask FDA commissioner nominee Robert Califf about drug prices during his confirmation hearing – so eager that the HELP Committee chairman almost forgot to let Califf make an opening statement.
Alexander recovered quickly, allowed Califf his introductory five minutes, and then again launched into an inquiry about ANDA review times,...
Welcome to Pink Sheet
Create an account to read this article
Already a subscriber?